Florent Morio
Prof Florent Morio is an expert in Infectiology at Centre Hospitalier Universitaire de Nantes (France). As of October 2026, ScienceLeadR ranks Florent Morio in the top 1% of experts worldwide for Mycoses. Florent Morio has authored 235 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 595 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Critical Care - Public Health - Transplantation
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 235
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Decoding candidemia in critically ill patients: unsupervised clustering identifies three unique phenotypes. PMID 42365321 — mortality, phenotype, candidemia, critical illness, cluster analysis, intensive care units, catheters | Crit Care | 2026 | 1 |
| Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a prospective observational cohort study. PMID 42269840 — mortality, bacterial infections, pneumocystis carinii, lung, heart, pneumocystis, neoplasms, cohort studies, kidney, liver, pneumonia, transplants, pneumonia, pneumocystis, communicable diseases, transplantation | J Infect | 2026 | 0 |
| Endocarditis Due to Scedosporium spp and Lomentospora prolificans: Case Series and Literature Review. PMID 42238380 — endocarditis, mycoses, transplants, scedosporium | Open Forum Infect Dis | 2026 | 0 |
| Assessing Laboratory Capacity for Diagnosis of Fungal Infections in France: A Multicentre survey within the SINFONI Network. PMID 42133464 — research design, yeasts, laboratories, biomarkers, mycoses, diagnosis, infections | Med Mycol | 2026 | 0 |
| A step toward defining optimal liposomal amphotericin B treatment duration in pulmonary mucormycosis: results from emulated trials. PMID 42053464 — mortality, mucormycosis, duration of therapy, triazoles, drug therapy, amphotericin b, therapeutics, antiviral agents | Antimicrob Agents Chemother | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 3
LeadR Networks
Main global connection map